With different results, a study conducted with 107 Korean patients with wAMD receiving intravitreal ranibizumab treatment found a prevalence of depression of 26.2 %, which is consistent with the literature pre-anti-VEGF treatments [15]. Here, VEGFA is linked to major depressive disorder.